Yup. We may benefit from more accurate diagnosis, but the treatment recommendations are all going to be orthodox pharma approved. The moment it recommends anything that reduces the potential treatment billed amount, it will be sidelined until the algorithm is changed.
Yup. We may benefit from more accurate diagnosis, but the treatment recommendations are all going to be orthodox pharma approved. The moment it recommends anything that reduces the potential treatment billed amount, it will be sidelined until the algorithm is changed.
🎯